KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $89.5 million.

  • Cme Group's Share-based Compensation rose 18.23% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.0 million, marking a year-over-year increase of 7.27%. This contributed to the annual value of $89.5 million for FY2024, which is 7.96% up from last year.
  • Cme Group's Share-based Compensation amounted to $89.5 million in FY2024, which was up 7.96% from $82.9 million recorded in FY2023.
  • In the past 5 years, Cme Group's Share-based Compensation registered a high of $96.0 million during FY2020, and its lowest value of $75.2 million during FY2021.
  • Over the past 3 years, Cme Group's median Share-based Compensation value was $84.3 million (recorded in 2022), while the average stood at $85.6 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first skyrocketed by 31.33% in 2020, then decreased by 21.67% in 2021.
  • Yearly analysis of 5 years shows Cme Group's Share-based Compensation stood at $96.0 million in 2020, then decreased by 21.67% to $75.2 million in 2021, then climbed by 12.10% to $84.3 million in 2022, then dropped by 1.66% to $82.9 million in 2023, then grew by 7.96% to $89.5 million in 2024.